The Food and Drug Administration (FDA) has approved a breast implant for women undergoing reconstructive or revision surgery.
Global pharmaceutical company Allergan has received approval from the US Food and Drug Administration (FDA) to market the Natrelle Inspira Cohesive breast implants
Breast implant manufacturer Mentor has received FDA approval to market MemoryGel Xtra silicone gel-filled breast implants in the US.
Distributor Q Medical has become the exclusive UK distributor for B-Lite breast implants.
The Food and Drug Administration (FDA) has issued a warning concerning reports of magnetic interference between breast tissue expanders with magnetic injection ports and other implantable cardioverter-defibrillators (ICDs) or pacemakers in patients.
The aesthetic manufacturer, Cynosure, has announced today that they have received FDA clearance to market PicoSure Focus for the treatment of acne scars. The treatment uses laser technology that claims to revitalise the skin and erase imperfections in just 30 minutes.
The Food and Drug Administration (FDA) has approved Jeuveau, a botulinum toxin type A, for the temporary improvement in the appearance of moderate to severe glabellar lines.
The Food and Drugs Administration has approved Exilis Elite as temporary reduction of cellulite treatment.
The Food and Drug Administration (FDA) has approved the Taltz injection to treat adults with moderate-to-severe psoriasis.
The Lightfusion LED platform has been approved by the US Food and Drug Administration (FDA) as a Class 2 medical device for the treatment of periorbital wrinkles.